Log in

canadian entrepreneurs

in life science


  • May 18, 2021 5:53 PM | Richard Ayllon (Administrator)

    Check-out the JLabs Toronto website for application details for Quick Fire Challenge Opportunities.

    • Advancing Joint Replacement Surgery | Deadline: June 18, 2021

    Up to $50k in grant funding, access to global JLABS networking, and mentoring.

    • Decoding Disparities | Deadline: June 25, 2021

    Grant funding in increments up to $200k, $100k, or $50k, access to global JLABS networking, and mentoring.

    • Improving Detection of AL Amyloidosis (IDEA) | Deadline: July 16, 2021
      Grant funding in increments up to $250k, $150k, or $50k, access to global JLABS networking, and mentoring.

     More Info

  • April 17, 2021 9:00 PM | Richard Ayllon (Administrator)

    We are happy to share details for an upcoming webinar event presented by EY Canada (a CELS Valley Ready lead Sponsor)

    Wednesday May 12/2021, Noon (ET)

    Changing the rules of the game: how the COVID-19 pandemic has impacted the Canadian life sciences sector - A virtual discussion

    One year into the COVID-19 pandemic, the impacts are felt widely across the life sciences sector. Canadian companies in this industry have experienced unprecedented challenges and immense pressure to pivot rapidly. Despite these exceptional circumstances, the sector has weathered the pandemic much better than originally predicted.

    Yet, one thing cannot be ignored: the rules of the game for this sector have changed over the last year and further transformation is likely.  Key topics:

    • Canadian vaccine manufacturing capabilities and capacity
    • The impact of Canadian Environmental and Social and Corporate Governance (ESG) on life sciences financing and innovation across the country.

    For more details and registration click the box below:

    More Info

  • April 17, 2021 8:25 PM | Richard Ayllon (Administrator)

    From our US East Coast friends, Canadian Entrepreneurs in New England (CENE), we are happy to share details for their upcoming webinar. 

    Wednesday April 28, 3 PM (ET) 

    A Fireside Chat With André Picard - Systemic Inequities in Healthcare stemming from the Coronavirus pandemicModerated by Heidi Legg, Founder and editor of The Editorial 


    The coronavirus pandemic has exposed the systemic inequities in healthcare, specifically among the most vulnerable populations.

    André and Heidi will discuss current conditions and the next steps needed to create change.

    André Picard health reporter and columnist for the Globe and Mail. Also, he is  the author of five bestselling books.

    André is an eight-time nominee for the National Newspaper Awards, Canada’s top journalism prize, and past winner of a prestigious Michener Award for Meritorious Public Service Journalism. He was named Canada’s first "Public Health Hero" by the Canadian Public Health Association, and a "Champion of Mental Health" by the Canadian Alliance on Mental Illness and Mental Health, and received the Queen Elizabeth II Diamond Jubilee Medal for his dedication to improving healthcare.

    Heidi Legg is an American/Canadian writer and journalist. She is currently a Research Fellow at the Institute of Quantitative Social Science at Harvard working on the Future of Media Project. 

    For more info and free registration click the box below:

    More Info

  • March 19, 2021 6:47 PM | Richard Ayllon (Administrator)

    Canadian Life Science companies find the right investors in the Bay Area through Silicon Valley Bank's (SVB) CIPHERBIO.

    It is a free resource (developed by SVB) for life science & healthcare startups to find VC’s that would be a good fit for them (and has also grown into a great tool for investment news and industry insights) – it breaks down markets into sectors and subsectors (including therapeutic areas for biotech).

    It has been a huge success in the US with great insights into investors, companies and accelerators

    Check it out


  • March 07, 2021 6:24 PM | Richard Ayllon (Administrator)

    Silicon Valley Bank shares their 2020 annual review of Healthcare Investments & Exits and Healthcare 2021 Outlook. Available at the link below

    2020 was quite an active year for investment in life sciences.  2021 looks to be equally promising.

    Thank you to CELS Gold sponsor:  Silicon Valley Bank

    SVB 2020 Review

  • March 03, 2021 1:38 PM | Richard Ayllon (Administrator)

    John Lewis, CEO Entos Pharmaceuticals was a CELS VR webinar guest speaker on February 4th, 2021

    Entos keeps moving ahead.  Read the story and press release below.  

    Edmonton-based Entos Pharmaceuticals has partnered with Alberta Cell Therapy Manufacturing (ACTM) and The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) to manufacture and prepare its COVID-19 DNA vaccine for clinical trials.

    Entos - News Story

    Entos - Press Release

  • January 15, 2021 7:31 AM | Richard Ayllon (Administrator)

    As business adapts to the new normal and virtual meetings.  Some of the classic meeting events that kick-off the Life Science Investor calendar year are being rethought. What do you think?

    Read The Article

  • December 10, 2020 1:51 PM | Richard Ayllon (Administrator)

    From Demo Day a few key take-aways from our Guest Speakers:

    Fireside Chat: Hidden Gems - Optimizing Opportunities for Life Science Companies in the US and Canada

    • Brian Courtney, CEO of Conavi Medical and Interventional Cardiologist and Clinician Scientist at Sunnybrook Health Sciences Centre
    • Cheryl Reicin, Chair of Life Sciences Practice, Torys LLP with Brian Courtney, 

    Keynote Talk - Motivation to invest in early stage Life Science companies

    • Vik Bajaj, Managing Director, Foresite Capital
    • Anne Woods, Managing Director - Life Sciences & Healthcare SVB


    • At many provincial and federal levels they are looking to see how Canadian health care move from being less of a cost center and more of an economic zone.
    • What's very important for any region is to create an ecosystem that is resilient to the failure of multiple companies. That's the magic of clusters in Silicon Valley.
    • The goal is to have the greatest impact on a patient's life. As life science investors we strive to achieve the greatest impact possible with the greatest return.
    • Startups need people who went from small to big. People who went through the transitions, because they would have been through some of the battles that you should anticipate as an entrepreneur going forward.

    Both talks are on the CELS VR Demo Day On-Demand Replay:

    play video 

    password required: =b2gxfN3

  • December 03, 2020 8:00 AM | Richard Ayllon (Administrator)

    The pandemic is ushering in the next trillion-dollar industry.  Tech Investors and Tech giants adjusting to the realities of a regulated environment.

    Canada is well suited to thrive in this great market of opportunity. 

    Check out the story at economist.com (free article conditions or subscription required)

    Go To Article


  • December 02, 2020 3:56 PM | Richard Ayllon (Administrator)

    An invitation from BIOTECanada - for JPM 2021 week

    You're invited to Connect with Canada, a networking opportunity bringing together healthcare companies, industry leaders, investors, business development reps, and policymakers to connect prior to JP Morgan, Biotech Showcase, and other conferences normally held in San Francisco.

    While we can't host you for breakfast this time, we still want to ensure you stay connected with your industry colleagues. Join us to kick off another promising week of partnerships and growth.

    Get ready for your first online networking event of the new year! Connect with us on Wednesday, January 6 to get energized for the week ahead.

    This event will include both casual networking and welcome remarks from a handful of speakers. We will provide more detail in the coming weeks on the agenda and online platform. Register to stay in the loop.



© 2023 Canadian Entrepreneurs in Life Science. All Rights Reserved.